Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Director/PDMR Shareholding

10 Mar 2020 16:51

RNS Number : 6731F
Royal Bank of Scotland Group PLC
10 March 2020
 

10 March 2020

The Royal Bank of Scotland Group plc

 

 

 

INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY (PDMRs) IN ACCORDANCE WITH ARTICLE 19 OF THE EU MARKET ABUSE REGULATION 596/2014

 

 

1. The Royal Bank of Scotland Group plc (the Company) announces that conditional long term incentive (LTI) or deferred awards over ordinary shares of ÂŁ1 each in the Company (Shares) (ISIN: GB00B7T77214), have been granted on 9 March 2020 under the RBS 2014 Employee Share Plan (the Plan) to the PDMRs set out below:-

 

Name of PDMR

Award

Position of PDMR

Maximum no. of

Shares eligible to vest

Vanessa Bailey

LTI

Chief Risk Officer, NatWest Holdings

411,451

Robert Begbie

Deferred

Interim CEO, NatWest Markets

258,626

 

Helen Cook

LTI

Chief HR Officer

529,008

Peter Flavel

Deferred

CEO, Private Banking

288,016

 

Bruce Fletcher

LTI

Chief Risk Officer, RBS Group

499,618

Andrew McLaughlin

LTI

CEO, RBS International

446,718

Simon McNamara

LTI

Chief Administrative Officer

587,786

Les Matheson

LTI

CEO, Personal Banking

587,786

Katie Murray

LTI

Chief Financial Officer

646,565

Alison Rose

LTI

Chief Executive Officer

881,679

John-Paul Thwaite

Deferred

CEO, Commercial Banking

199,848

 

 

The market price per Share used on the grant of the above awards was ÂŁ1.701. The above transactions took place outside of a trading venue.

 

LTI awards were subject to a pre-grant performance assessment and a further performance assessment will take place at the end of three years. Subject to this pre-vest assessment, LTI awards will be eligible to vest between the years 2023 and 2027. Deferred awards will be eligible to vest between the years 2020 and 2027.

 

Malus provisions will apply up until vest and clawback provisions will apply for a period of seven years from the date of grant, extended to ten years, for relevant PDMRs, if events are under investigation at the end of the seven year period. Vested Shares retained after payment of associated tax liabilities will be subject to a twelve month retention period.

 

 

2. The Company announces that conditional LTI and deferred awards, including buy-outs, over Shares vested on 9 March 2020 to the PDMRs set out below. The awards were granted under the Plan between March 2015 and March 2019. The number of Shares withheld to meet associated tax liabilities arising on vesting and the number of vested Shares retained by each PDMR is set out below:-

 

Name of PDMR

Position of PDMR

Award

No. of Shares vested

No. of Shares withheld to satisfy associated tax liability

No. of vested Shares retained

Vanessa Bailey

Chief Risk Officer, NatWest Holdings

LTI

36,318

17,071

19,247

Deferred

12,693

5,966

6,727

Robert Begbie

Interim CEO, NatWest Markets

LTI

23,922

11,484

12,438

Deferred

64,200

30,818

33,382

Helen Cook

Chief HR Officer

LTI

19,368

9,104

10,264

Deferred

9,320

4,381

4,939

Peter Flavel

CEO, Private Banking

LTI

29,824

14,018

15,806

Deferred

41,278

19,402

21,876

Bruce Fletcher

Chief Risk Officer, RBS Group

Buy-out

68,033

31,976

36,057

Andrew McLaughlin1

CEO, RBS International

LTI

44,855

-

44,855

Deferred

80,466

-

80,466

Simon McNamara

Chief Administrative Officer

LTI

352,008

168,965

183,043

Les Matheson

CEO, Personal Banking

LTI

336,483

161,513

174,970

Katie Murray

Chief Financial Officer

LTI

9,143

4,298

4,845

Deferred

61,307

28,816

32,491

Alison Rose

Chief Executive Officer

LTI

422,920

198,774

224,146

John-Paul Thwaite

CEO, Commercial Banking

LTI

8,865

4,167

4,698

Deferred

47,799

22,467

25,332

1. The award was granted when the PDMR was resident in Jersey and therefore is taxable in Jersey only and not in the UK. No employer tax withholding is required under Jersey law. The Jersey income tax payable in respect of the vesting of the award will be paid by the PDMR directly to the Jersey tax authority.

 

The market price used to meet associated tax liabilities was ÂŁ1.409. The above transactions took place outside of a trading venue.

 

Vested Shares retained after payment of associated tax liabilities will be subject to retention periods of between six and twelve months. For Mr Fletcher's awards, vested Shares, after payment of associated tax liabilities, will be subject to retention periods of between six and thirty months, in line with the original terms of his forfeited HSBC awards.

 

 

3. The Company announces that Shares were delivered to PDMRs on 9 March 2020, as set out below. The Shares delivered represent payment of a fixed share allowance for the three month period ending 31 March 2020 and have been calculated using a share price of ÂŁ1.701.

 

The number of Shares delivered, the number of Shares withheld to meet associated tax liabilities and the number of Shares retained by each PDMR is as follows:-

 

Name of PDMR

Position of PDMR

No. of Shares delivered

No. of Shares withheld to satisfy associated tax liability

No. of Shares retained

Vanessa Bailey

Chief Risk Officer, NatWest Holdings

36,737

17,267

19,470

Helen Cook

Chief HR Officer

18,001

8,461

9,540

Peter Flavel

Chief Executive Officer, Private Banking

33,084

15,550

17,534

Bruce Fletcher

Chief Risk Officer

44,084

20,720

23,364

Andrew McLaughlin1

CEO, RBS International

22,042

-

22,042

Simon McNamara

Chief Administrative Officer

47,758

22,924

24,834

Les Matheson

CEO, Personal Banking

44,084

21,161

22,923

John-Paul Thwaite

CEO, Commercial Banking

33,063

15,540

17,523

1. The award was granted when the PDMR was resident in Jersey and therefore is taxable in Jersey only and not in the UK. No employer tax withholding is required under Jersey law. The Jersey income tax payable in respect of the vesting of the award will be paid by the PDMR directly to the Jersey tax authority.

 

The market price used to determine the number of Shares withheld to meet associated tax liabilities was ÂŁ1.409. The above transactions took place outside of a trading venue. Shares retained after payment of associated tax liabilities will be held on behalf of PDMRs and will be released in instalments over a three year period.

 

4. The Company announces that the PDMR set out below has purchased Shares on the date and at the price indicated:-

 

Name of PDMR

Position of PDMR

No. of Shares purchased

Purchase price

Date of transaction

Patrick Flynn

Non-executive director

20,000

ÂŁ1.476

10 March 2020

 

The transaction took place on the London Stock Exchange (XLON).

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

For further information contact:-

 

RBSG Investor RelationsAlexander HolcroftHead of Investor Relations+44(0)20 7672 1758

 

RBSG Media Relations

+44(0)131 523 4205

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFSRVTIILII
Date   Source Headline
5th Nov 20184:21 pmRNSPublication of Suppl.Prospcts
2nd Nov 20185:25 pmRNSPublication of 2018 EBA EU-wide stress test result
2nd Nov 20182:10 pmRNSDirector/PDMR Shareholding
1st Nov 20187:00 amRNSUK intra-Group capital & liquidity arrangements
31st Oct 20182:38 pmRNSTotal Voting Rights
31st Oct 20187:00 amRNSDividend Declaration
30th Oct 20184:05 pmRNSDirector/PDMR Shareholding
29th Oct 20183:46 pmRNSDirector/PDMR Shareholding
26th Oct 20187:00 amRNSInterim Management Statement
9th Oct 20182:07 pmRNSForm 8.3 - CareTech Holdings
4th Oct 201812:43 pmRNSForm 8.3 - CareTech Holdings
4th Oct 201812:25 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 20183:00 pmRNSDirector/PDMR Shareholding
28th Sep 201812:32 pmRNSTotal Voting Rights
25th Sep 201811:23 amRNSPricing of USD Fixed Rate to Floating Rate Notes
25th Sep 20187:00 amRNSBofAML Annual Financial CEO Conference
24th Sep 20189:00 amRNSRBS Investor SeminarUK Personal & Business Banking
17th Sep 201812:05 pmRNSPublication of Final Terms
13th Sep 201812:25 pmRNSForm 8.3 - CareTech Holdings
13th Sep 20188:00 amRNSBarclays Global Financial Services Conference
3rd Sep 20186:00 pmRNSPublication of Final Terms
31st Aug 20184:42 pmRNSTotal Voting Rights
31st Aug 20184:15 pmRNSNatWest Markets N.V. Interim Results 2018
22nd Aug 20185:01 pmRNSDividend Declaration
21st Aug 20183:32 pmRNSPublication of Suppl.Prospcts
17th Aug 20187:00 amRNSDirectorate Change
15th Aug 20187:00 amRNSDeclaration of Interim Dividend
13th Aug 20189:00 amRNSUpdate on ring-fencing plans
3rd Aug 20182:25 pmRNSForm 8.3 - [CareTech Holdings]
3rd Aug 20187:00 amRNSHalf-year Report
31st Jul 20182:44 pmRNSUpdate on ring-fencing plans
31st Jul 201812:04 pmRNSTotal Voting Rights
26th Jul 201812:17 pmRNSForm 8.3 - CareTech Holdings PLC
23rd Jul 20182:10 pmRNSForm 8.3 - CareTech Holdings plc
17th Jul 201811:46 amRNSRBS welcomes credit ratings action by Moody's
16th Jul 20186:18 pmRNSAllotment and Issue of New Ordinary Shares
16th Jul 20184:18 pmRNSForm 8.3 - CareTech Holdings plc
2nd Jul 20182:47 pmRNSCapital reduction - notice of completion
29th Jun 201812:51 pmRNSTotal Voting Rights
27th Jun 20184:36 pmRNSHolding(s) in Company
25th Jun 201811:52 amRNSPublication of Final Terms
22nd Jun 20185:28 pmRNSPublication of Final Terms
21st Jun 201811:52 amRNSPricing of USD Dual-Tranche Notes
8th Jun 20189:23 amRNSTR-1 Notification of major shareholdings
7th Jun 20189:00 amRNSGoldman Sachs European Financials Conference
5th Jun 20187:00 amRNSDisposal of approximately 7.7% of RBS Group plc.
4th Jun 20184:36 pmRNSIntention to dispose of c7.7% of RBS Group plc.
31st May 20185:32 pmRNSTotal Voting Rights
31st May 20184:30 pmRNSRBS notes credit rating actions by Standard&Poor's
31st May 201812:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.